Loading…
Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
BackgroundRenal dysfunction is considered a confounding variable in the interpretation of B-type natriuretic peptides (BNPs) and their amino-terminal fragments (NT-ProBNP) in patients with heart failure (HF). Our aim was to investigate the prognostic utility of BNPs and NT-proBNP in HF outpatients w...
Saved in:
Published in: | Clinical kidney journal 2013-02, Vol.6 (1), p.55-62 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3 |
container_end_page | 62 |
container_issue | 1 |
container_start_page | 55 |
container_title | Clinical kidney journal |
container_volume | 6 |
creator | Waldum, Bård Stubnova, Viera Westheim, Arne S. Omland, Torbjørn Grundtvig, Morten Os, Ingrid |
description | BackgroundRenal dysfunction is considered a confounding variable in the interpretation of B-type natriuretic peptides (BNPs) and their amino-terminal fragments (NT-ProBNP) in patients with heart failure (HF). Our aim was to investigate the prognostic utility of BNPs and NT-proBNP in HF outpatients with renal dysfunction, and compare the prognostic significance of the corresponding BNP/NT-ProBNP levels in patients with and without renal dysfunction.MethodsA total of 2076 patients from 13 HF clinics in the Norwegian Heart Failure Registry were investigated. The BNP/NT-ProBNP levels were categorized centre-wise into four groups using the quartile limits found in patients with preserved renal function. Patients with renal dysfunction, i.e. glomerular filtration rate (GFR) ≤60 mL/min/1.73 m2, were then assigned to BNP groups 1–4 centre-wise according to their level of natriuretic peptides.ResultsRenal dysfunction was present in 37.5% of the patients, of whom the majority (59.1%) had levels of natriuretic peptide in the highest BNP group. Patients with renal dysfunction and BNP levels in the lower three BNP groups had similar 2-year survival as patients without renal dysfunction and comparable BNP levels [crude hazard ratio (HR) 1.25, 95% CI 0.82–1.89, P = 0.302, multiple adjusted HR 0.85, 95% CI 0.54–1.33, P = 0.457]. Beyond 2 years of follow-up, renal dysfunction predicted all-cause mortality irrespective of the level of natriuretic peptides at the start of follow-up.ConclusionIn HF outpatients, the BNP/NT-ProBNP level predicted 2-year mortality irrespective of renal function and provided important prognostic information on patients with renal dysfunction. |
doi_str_mv | 10.1093/ckj/sfs174 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3888094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ckj/sfs174</oup_id><sourcerecordid>1826584476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3</originalsourceid><addsrcrecordid>eNp9kU9LHTEUxUOpVFE3_QAlm0IRpubfzGQ2gj5aKwi6aNchL7nxxc5LpklGed_eyLMP3Xg398L5ce6Bg9BnSr5TMvBT8_f-NLtMe_EBHTAiZCNbyj_ubtLuo-Oc70mdqhDRfkL7TAjGaE8PkLtN8S7EXLzBc_GjLxscHb5oymYCHHRJfk7wrE4wFW8hYx_wpIuHUDJ-9GWFV6BTwU77saJYB4sTBD1iu8luDqb4GI7QntNjhuOXfYj-_Pzxe_Grub65vFqcXzdGEFkaTamTNeKSD66HVnBjRcc6QYYOlpoR4HYYWtCG99rZ3joqQFgiHekY48zxQ3S29Z3m5RqsqSGTHtWU_FqnjYraq7dK8Ct1Fx8Ul1KSQVSDby8GKf6bIRe19tnAOOoAcc6KSta1Uoi-q-jJFjUp5pzA7d5Qop67UbUbte2mwl9eB9uh_5uowNctEOfpPaMnkweajg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826584476</pqid></control><display><type>article</type><title>Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction</title><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Waldum, Bård ; Stubnova, Viera ; Westheim, Arne S. ; Omland, Torbjørn ; Grundtvig, Morten ; Os, Ingrid</creator><creatorcontrib>Waldum, Bård ; Stubnova, Viera ; Westheim, Arne S. ; Omland, Torbjørn ; Grundtvig, Morten ; Os, Ingrid</creatorcontrib><description>BackgroundRenal dysfunction is considered a confounding variable in the interpretation of B-type natriuretic peptides (BNPs) and their amino-terminal fragments (NT-ProBNP) in patients with heart failure (HF). Our aim was to investigate the prognostic utility of BNPs and NT-proBNP in HF outpatients with renal dysfunction, and compare the prognostic significance of the corresponding BNP/NT-ProBNP levels in patients with and without renal dysfunction.MethodsA total of 2076 patients from 13 HF clinics in the Norwegian Heart Failure Registry were investigated. The BNP/NT-ProBNP levels were categorized centre-wise into four groups using the quartile limits found in patients with preserved renal function. Patients with renal dysfunction, i.e. glomerular filtration rate (GFR) ≤60 mL/min/1.73 m2, were then assigned to BNP groups 1–4 centre-wise according to their level of natriuretic peptides.ResultsRenal dysfunction was present in 37.5% of the patients, of whom the majority (59.1%) had levels of natriuretic peptide in the highest BNP group. Patients with renal dysfunction and BNP levels in the lower three BNP groups had similar 2-year survival as patients without renal dysfunction and comparable BNP levels [crude hazard ratio (HR) 1.25, 95% CI 0.82–1.89, P = 0.302, multiple adjusted HR 0.85, 95% CI 0.54–1.33, P = 0.457]. Beyond 2 years of follow-up, renal dysfunction predicted all-cause mortality irrespective of the level of natriuretic peptides at the start of follow-up.ConclusionIn HF outpatients, the BNP/NT-ProBNP level predicted 2-year mortality irrespective of renal function and provided important prognostic information on patients with renal dysfunction.</description><identifier>ISSN: 2048-8505</identifier><identifier>EISSN: 2048-8513</identifier><identifier>DOI: 10.1093/ckj/sfs174</identifier><identifier>PMID: 24422171</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Original Contributions</subject><ispartof>Clinical kidney journal, 2013-02, Vol.6 (1), p.55-62</ispartof><rights>The Author 2012. Published by Oxford University Press on behalf of ERA-EDTA. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3</citedby><cites>FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888094/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888094/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,1604,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24422171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waldum, Bård</creatorcontrib><creatorcontrib>Stubnova, Viera</creatorcontrib><creatorcontrib>Westheim, Arne S.</creatorcontrib><creatorcontrib>Omland, Torbjørn</creatorcontrib><creatorcontrib>Grundtvig, Morten</creatorcontrib><creatorcontrib>Os, Ingrid</creatorcontrib><title>Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction</title><title>Clinical kidney journal</title><addtitle>Clin Kidney J</addtitle><description>BackgroundRenal dysfunction is considered a confounding variable in the interpretation of B-type natriuretic peptides (BNPs) and their amino-terminal fragments (NT-ProBNP) in patients with heart failure (HF). Our aim was to investigate the prognostic utility of BNPs and NT-proBNP in HF outpatients with renal dysfunction, and compare the prognostic significance of the corresponding BNP/NT-ProBNP levels in patients with and without renal dysfunction.MethodsA total of 2076 patients from 13 HF clinics in the Norwegian Heart Failure Registry were investigated. The BNP/NT-ProBNP levels were categorized centre-wise into four groups using the quartile limits found in patients with preserved renal function. Patients with renal dysfunction, i.e. glomerular filtration rate (GFR) ≤60 mL/min/1.73 m2, were then assigned to BNP groups 1–4 centre-wise according to their level of natriuretic peptides.ResultsRenal dysfunction was present in 37.5% of the patients, of whom the majority (59.1%) had levels of natriuretic peptide in the highest BNP group. Patients with renal dysfunction and BNP levels in the lower three BNP groups had similar 2-year survival as patients without renal dysfunction and comparable BNP levels [crude hazard ratio (HR) 1.25, 95% CI 0.82–1.89, P = 0.302, multiple adjusted HR 0.85, 95% CI 0.54–1.33, P = 0.457]. Beyond 2 years of follow-up, renal dysfunction predicted all-cause mortality irrespective of the level of natriuretic peptides at the start of follow-up.ConclusionIn HF outpatients, the BNP/NT-ProBNP level predicted 2-year mortality irrespective of renal function and provided important prognostic information on patients with renal dysfunction.</description><subject>Original Contributions</subject><issn>2048-8505</issn><issn>2048-8513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kU9LHTEUxUOpVFE3_QAlm0IRpubfzGQ2gj5aKwi6aNchL7nxxc5LpklGed_eyLMP3Xg398L5ce6Bg9BnSr5TMvBT8_f-NLtMe_EBHTAiZCNbyj_ubtLuo-Oc70mdqhDRfkL7TAjGaE8PkLtN8S7EXLzBc_GjLxscHb5oymYCHHRJfk7wrE4wFW8hYx_wpIuHUDJ-9GWFV6BTwU77saJYB4sTBD1iu8luDqb4GI7QntNjhuOXfYj-_Pzxe_Grub65vFqcXzdGEFkaTamTNeKSD66HVnBjRcc6QYYOlpoR4HYYWtCG99rZ3joqQFgiHekY48zxQ3S29Z3m5RqsqSGTHtWU_FqnjYraq7dK8Ct1Fx8Ul1KSQVSDby8GKf6bIRe19tnAOOoAcc6KSta1Uoi-q-jJFjUp5pzA7d5Qop67UbUbte2mwl9eB9uh_5uowNctEOfpPaMnkweajg</recordid><startdate>20130201</startdate><enddate>20130201</enddate><creator>Waldum, Bård</creator><creator>Stubnova, Viera</creator><creator>Westheim, Arne S.</creator><creator>Omland, Torbjørn</creator><creator>Grundtvig, Morten</creator><creator>Os, Ingrid</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130201</creationdate><title>Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction</title><author>Waldum, Bård ; Stubnova, Viera ; Westheim, Arne S. ; Omland, Torbjørn ; Grundtvig, Morten ; Os, Ingrid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Original Contributions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waldum, Bård</creatorcontrib><creatorcontrib>Stubnova, Viera</creatorcontrib><creatorcontrib>Westheim, Arne S.</creatorcontrib><creatorcontrib>Omland, Torbjørn</creatorcontrib><creatorcontrib>Grundtvig, Morten</creatorcontrib><creatorcontrib>Os, Ingrid</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical kidney journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waldum, Bård</au><au>Stubnova, Viera</au><au>Westheim, Arne S.</au><au>Omland, Torbjørn</au><au>Grundtvig, Morten</au><au>Os, Ingrid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction</atitle><jtitle>Clinical kidney journal</jtitle><addtitle>Clin Kidney J</addtitle><date>2013-02-01</date><risdate>2013</risdate><volume>6</volume><issue>1</issue><spage>55</spage><epage>62</epage><pages>55-62</pages><issn>2048-8505</issn><eissn>2048-8513</eissn><abstract>BackgroundRenal dysfunction is considered a confounding variable in the interpretation of B-type natriuretic peptides (BNPs) and their amino-terminal fragments (NT-ProBNP) in patients with heart failure (HF). Our aim was to investigate the prognostic utility of BNPs and NT-proBNP in HF outpatients with renal dysfunction, and compare the prognostic significance of the corresponding BNP/NT-ProBNP levels in patients with and without renal dysfunction.MethodsA total of 2076 patients from 13 HF clinics in the Norwegian Heart Failure Registry were investigated. The BNP/NT-ProBNP levels were categorized centre-wise into four groups using the quartile limits found in patients with preserved renal function. Patients with renal dysfunction, i.e. glomerular filtration rate (GFR) ≤60 mL/min/1.73 m2, were then assigned to BNP groups 1–4 centre-wise according to their level of natriuretic peptides.ResultsRenal dysfunction was present in 37.5% of the patients, of whom the majority (59.1%) had levels of natriuretic peptide in the highest BNP group. Patients with renal dysfunction and BNP levels in the lower three BNP groups had similar 2-year survival as patients without renal dysfunction and comparable BNP levels [crude hazard ratio (HR) 1.25, 95% CI 0.82–1.89, P = 0.302, multiple adjusted HR 0.85, 95% CI 0.54–1.33, P = 0.457]. Beyond 2 years of follow-up, renal dysfunction predicted all-cause mortality irrespective of the level of natriuretic peptides at the start of follow-up.ConclusionIn HF outpatients, the BNP/NT-ProBNP level predicted 2-year mortality irrespective of renal function and provided important prognostic information on patients with renal dysfunction.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>24422171</pmid><doi>10.1093/ckj/sfs174</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2048-8505 |
ispartof | Clinical kidney journal, 2013-02, Vol.6 (1), p.55-62 |
issn | 2048-8505 2048-8513 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3888094 |
source | Oxford Journals Open Access Collection; PubMed Central |
subjects | Original Contributions |
title | Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A47%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20utility%20of%20B-type%20natriuretic%20peptides%20in%20patients%20with%20heart%20failure%20and%20renal%20dysfunction&rft.jtitle=Clinical%20kidney%20journal&rft.au=Waldum,%20B%C3%A5rd&rft.date=2013-02-01&rft.volume=6&rft.issue=1&rft.spage=55&rft.epage=62&rft.pages=55-62&rft.issn=2048-8505&rft.eissn=2048-8513&rft_id=info:doi/10.1093/ckj/sfs174&rft_dat=%3Cproquest_pubme%3E1826584476%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-a11f8045b39f7e543cd46264096eba20e3d995eac37afd7df14e4d08f062232f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1826584476&rft_id=info:pmid/24422171&rft_oup_id=10.1093/ckj/sfs174&rfr_iscdi=true |